Simulations Plus Inc.
NASDAQ:SLP 3:02:12 PM EDT
| Market Cap (Intraday) | 1.07B |
| Current PE | 98.99 |
| Forward PE | 98.56 |
| 2yr Forward PE | 83.16 |
| 10-Day MA | $54.00 |
| 50-Day MA | $56.48 |
| 200-Day MA | $65.85 |
Simulations Plus Inc. Stock, NASDAQ:SLP
42505 10th Street West, Lancaster, California 93534-7059
Phone: +1.661.723.7723
Number of Employees: 137
Description
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. It operates through the following segments: Simulations Plus, Inc., Cognigen Corporation, DILIsym, and Lixoft. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.